Retrospective analysis of somatic mutations and clonal hematopoiesis in astronauts

[1]  D. Goukassian,et al.  Cell‐Free Mitochondrial DNA as a Potential Biomarker for Astronauts' Health , 2021, Journal of the American Heart Association.

[2]  Y. Izumiya,et al.  Somatic Mosaicism in Biology and Disease. , 2021, Annual review of physiology.

[3]  O. Weinberg,et al.  PHF6 Mutations in Hematologic Malignancies , 2021, Frontiers in Oncology.

[4]  K. Walsh,et al.  TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response , 2021, JCI insight.

[5]  A. Diaz-Artiles,et al.  Planetary extravehicular activity (EVA) risk mitigation strategies for long-duration space missions , 2021, NPJ microgravity.

[6]  F. Camargo,et al.  Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms , 2021, Cell stem cell.

[7]  Francine E. Garrett-Bakelman,et al.  Clonal Hematopoiesis Before, During, and After Human Spaceflight , 2020, Cell reports.

[8]  Maya N. Polackal,et al.  TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity , 2020, Cell reports.

[9]  Stuart M. Gardos,et al.  Cancer therapy shapes the fitness landscape of clonal hematopoiesis , 2020, Nature Genetics.

[10]  S. Karanika,et al.  Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden. , 2020, Blood advances.

[11]  K. Walsh,et al.  Cardiovascular Disease, Aging, and Clonal Hematopoiesis. , 2020, Annual review of pathology.

[12]  H. Hasselbalch,et al.  Prevalence and phenotypes of JAK2 V617F and Calreticulin mutations in a Danish general population. , 2019, Blood.

[13]  W. Gu,et al.  p53 modifications: exquisite decorations of the powerful guardian , 2019, Journal of molecular cell biology.

[14]  Rebecca S. Blue,et al.  Space Medicine in the Era of Civilian Spaceflight , 2019, The New England journal of medicine.

[15]  A. Tall,et al.  Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2V617F Mice , 2018, Circulation research.

[16]  D. Steensma.  Clinical Implications of Clonal Hematopoiesis , 2018, Mayo Clinic proceedings.

[17]  D. Goukassian,et al.  Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. , 2018, Journal of the American College of Cardiology.

[18]  M. Ladanyi,et al.  Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. , 2017, Cell stem cell.

[19]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[20]  Matthew A. Cooper,et al.  Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.

[21]  N. Bolli,et al.  Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling , 2017, Oncotarget.

[22]  S. Miyano,et al.  Dynamics of clonal evolution in myelodysplastic syndromes , 2016, Nature Genetics.

[23]  N. Socci,et al.  Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity , 2015, Nature Biotechnology.

[24]  H. Grallert,et al.  Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease , 2015, American journal of hematology.

[25]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[26]  G. Mufti,et al.  Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. , 2014, Blood.

[27]  Francis A. Cucinotta,et al.  Space Radiation Risks for Astronauts on Multiple International Space Station Missions , 2014, PloS one.

[28]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[29]  S. Bojesen,et al.  The JAK2 V617F somatic mutation, mortality and cancer risk in the general population , 2011, Haematologica.

[30]  Leif E. Peterson,et al.  NASA Study of Cataract in Astronauts (NASCA). Report 1: Cross-Sectional Study of the Relationship of Exposure to Space Radiation and Risk of Lens Opacity , 2009, Radiation research.

[31]  P. Mills,et al.  The effects of spaceflight on adrenergic receptors and agonists and cell adhesion molecule expression , 2002, Journal of Neuroimmunology.

[32]  F A Cucinotta,et al.  Space Radiation and Cataracts in Astronauts , 2001, Radiation research.

[33]  A. Moliterno,et al.  The roles of sex and genetics in the MPN. , 2022, International review of cell and molecular biology.

[34]  D. Lane,et al.  Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others , 2018, Nature Reviews Clinical Oncology.

[35]  Magali Olivier,et al.  TP53 mutations in human cancers: origins, consequences, and clinical use. , 2010, Cold Spring Harbor perspectives in biology.

[36]  M. Olivier,et al.  TP 53 Mutations in Human Cancers : Origins , Consequences , and Clinical Use , 2009 .